SGO 2025 | SGO

Saguaro cactus silhouette at sunset overlooking illuminated city with mountains in background

Save the date for SGO 2027 Annual Meeting on Women's Cancer

See you in Phoenix!

SGO 2026 Awards title on navy background with abstract teal and mauve design elements

SGO 2026 Awards

See the Award Winners

2026 Research Awards and Donor Appreciation event banner with abstract teal and purple design elements on navy background

2026 Research Awards and Donor Appreciation

See the Award Winners

Man in business suit speaking at SCO Annual Meeting on Women's Cancer podium with microphone

Meet SGO Incoming President, Matthew A. Powell, MD

Pembrolizumab Improves Survival in Platinum-Resistant Ovarian Cancer

Hope on the Horizon

Phase 3 RUBY trial demonstrated positive outcomes for patients with primary advanced or recurrent endometrial cancer.

Professional panel discussion with diverse speakers and attendees at a conference event

A Perfect Place to Lounge and Lean in

The Exhibit Hall’s Fellows’ Lounge provides young members with a comfortable place to network, organize, and recharge.

Click here to learn more about Avmapki Fakzynja Co-Pack

Click here to learn more about Avmapki Fakzynja Co-Pack

Read the latest about Avmapki Fakzynja Co-Pack (avutometinib capsules; defactinib tablets). Visit our website to learn more!

SISTER: All for one and one for all?

Group peer support alone does not improve treatment completion for Black women with high‑risk endometrial cancer, but a one-on-one human connection did.

SGO 2026 Awards title with abstract teal and mauve curved design elements on dark blue background

SGO 2026 Awards

High-caliber individuals are recognized for their work in research and service.

2026 Research Awards and Donor Appreciation event title with decorative teal and purple flowing design elements on dark blue background

2026 Research Awards and Donor Appreciation

Karen Lu, MD

Get to Know SGO’s Incoming President

Karen Lu, MD, brings a strong background and passion for building the gynecologic oncology community.

audience shot

A Potential New Detection Tool for Invasive Cervical Cancer

Circulating human papilloma virus DNA shows promise as a universal biomarker.

Ginger Gardner, MD, FACOG

Empowering Progress: The Foundation for Women's Cancer

The 2025 FWC strategic plan sets the course to improve outcomes for all patients.

A Potential Second-Line Treatment for Cervical Cancer

Combining BVAC-C and durvalumab in recurrent or metastatic cervical cancer.

Tamar Gootzen, MD

An Alternative Approach to Preventing Ovarian Cancer?

The ongoing TUBA-WISP II study could point the way to a new preventive approach for those at high risk for tubo-ovarian cancer.

Fang Jiang, MD, PhD

Changing the Course for First-Line, Low-Risk Gestational Trophoblastic Neoplasia

Angela Nolin, MD

It’s Time to Change the Diagnosis Protocol for Endometrial Cancer

Matthew A. Powell, MD

Tricky But Treatable

Kathleen N. Moore, MD

Durvalumab Plus Carboplatin and Paclitaxel Delivers One-Two Punch for Endometrial Cancer Treatment

Linda Duska, MD, MPH

Pembrolizumab Plus Chemotherapy Regimen Yields Clinically Positive Outcomes for Treatment of Locally Advanced Cervical Cancer

Welcome video

Watch: Welcome to Seattle

headshots of the program chairs

Masterclasses and Hands-On Learning Set the Pace for SGO 2025

Amanda Nickles Fader, MD

Q&A With SGO President Amanda Nickles Fader, MD

convention attendee using an iPad

Get the SGO 2025 Mobile App

Fund the Future. Honor a Legacy

Invited Speaker: Gretchen Schwarze